RAP PLATFORM
LIVE

Serial Number

97768059

Owner

CAMP4 THERAPEUTICS CORPORATION

Attorney

Christina M. Licursi

First Use Date

Jun 29, 2023

Filing Date

Jan 25, 2023

Add to watchlist:

No watchlists yet
View on USPTO

RAP PLATFORM Trademark

Serial Number: 97768059 • Registration: 7870935

RAP PLATFORM is a trademark filed by CAMP4 THERAPEUTICS CORPORATION on January 25, 2023. The trademark is classified under Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

CAMP4 THERAPEUTICS CORPORATION (8 trademarks)

One Kendall Square Bldg. 1400W STE 301
Cambridge, MA 02139

Entity Type: 03

Trademark Details

Filing Date

January 25, 2023

Registration Date

July 22, 2025

First Use Anywhere

June 29, 2023

First Use in Commerce

June 29, 2023

Published for Opposition

March 12, 2024

Goods & Services

Research and development of pharmaceutical, therapeutic and biopharmaceutical preparations and agents for the treatment of a variety of human and animal diseases and disorders, namely, autoimmune diseases and disorders, cardiovascular diseases and disorders, connective tissues diseases and disorders, dermatological diseases and disorders, enzyme deficiency diseases and disorders, gastrointestinal diseases and disorders, genetic diseases and disorders, genitourinary diseases and disorders, hematological diseases and disorders, immunoregulatory diseases and disorders, infectious diseases and disorders, inflammatory diseases and disorders, hepatic diseases and disorders, metabolic diseases and disorders, muscular diseases and disorders, neurological diseases and disorders, neuromuscular diseases and disorders, oncological diseases and disorders, ophthalmological diseases and disorders, rare diseases and disorders, renal diseases and disorders, reproductive disease and disorders, and respiratory diseases and disorders; research and development of technology in the field of pharmaceutical, therapeutic and biopharmaceutical preparations and agents; pharmaceutical drug development and drug discovery services; pharmaceutical research and analysis services using machine learning analytics relating to pharmaceutical drug development; scientific research, pharmaceutical research, medical research, technical consultation, and product development for others in the field of biotechnology and development of pharmaceutical, therapeutic, and biopharmaceutical preparations and agents

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jul 22, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Jul 22, 2025 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Jul 16, 2025 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Jun 27, 2025 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Jun 24, 2025 SUPC
USE AMENDMENT FILED
Nov 7, 2024 IUAF
TEAS STATEMENT OF USE RECEIVED
Nov 7, 2024 EISU
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
May 7, 2024 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 12, 2024 NPUB
PUBLISHED FOR OPPOSITION
Mar 12, 2024 PUBO
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 21, 2024 NPUB
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 21, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 8, 2024 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 7, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 6, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 6, 2024 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Nov 15, 2023 GNRN
NON-FINAL ACTION E-MAILED
Nov 15, 2023 GNRT
NON-FINAL ACTION WRITTEN
Nov 15, 2023 CNRT
ASSIGNED TO EXAMINER
Oct 23, 2023 DOCK
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
May 5, 2023 AMPX
ASSIGNED TO LIE
May 4, 2023 ALIE
TEAS VOLUNTARY AMENDMENT RECEIVED
Feb 2, 2023 PARI
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 30, 2023 NWOS
NEW APPLICATION ENTERED
Jan 28, 2023 NWAP